Profiel
Ritu Shah is Chief Executive Officer at ClostraBio, Inc. since 2022.
Ms. Shah is Advisory Board Member at Portal Innovations LLC starting in 2026.
Former roles include Vice President-Program Management at Novartis Gene Therapies, Inc. from 2017 to 2018, VP-Business Operations & Program Management at Levo Therapeutics, Inc. from 2018 to 2021, and Chief Operating Officer at Pyxis Oncology, Inc. Education includes an undergraduate degree from the University of Notre Dame.
Actieve functies van Ritu Shah
| Bedrijven | Functie | Begin |
|---|---|---|
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology Develops microbiome-modulating therapeutics | Algemeen Directeur | 01-12-2022 |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Consultant / Adviseur | 01-01-2026 |
Eerdere bekende functies van Ritu Shah
| Bedrijven | Functie | Einde |
|---|---|---|
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Corporate Officer/Principal | 01-03-2021 |
| AVEXIS INC | Corporate Officer/Principal | 01-07-2018 |
| PYXIS ONCOLOGY, INC. | Operationeel Directeur | - |
Opleiding van Ritu Shah
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Health Technology |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology Develops microbiome-modulating therapeutics | Health Technology |
Pyxis Oncology, Inc.
Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Finance |
















